SWOT Analysis for Dexcom Inc - Threats

Add SWOT widget to your site/app

Positive Breakout Second Resistance ( LTP > R2)

Price crossing above SMA20 today, and greater than SMA5

Stocks in Buy Zone with High Momentum Score Last Month

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

Relative Outperformance versus Industry over 1 Week

Mid-range Performer (DVM)

Rising Net Cash Flow and Cash from Operating activity

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Positive Breakout (LTP > R2)

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Positive Breakout (LTP > R1)

Top Gainers

Promoter decreasing their shareholding

Stocks with Quarter Change % less than Industry

PE higher than Industry PE

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Stocks Underperforming their Industry Price Change in the Quarter

Companies with Upcoming Results

Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts

Mutual Funds Decreased Shareholding in Past Month

MFs decreased their shareholding last quarter

Institutions decreased their shareholding last quarter